Rafael Rodríguez Rojas finished a Nuclear Physics degree in the Higher Institute of Nuclear Science and Technology, in Havana, Cuba. He obtained his master degree in Medical Physics at the University of Havana, performing his final thesis at the International Center for Neurological Restoration (CIREN). He worked as investigator at CIREN using multimodal neuroimaging to explore neurodegenerative diseases, brain injury, epilepsy and multiple sclerosis. He participated in development of computer-based technologies for image guided neurosurgery for the treatment of Parkinson’s disease, essential tremor and dystonia. He was awarded Associated Researcher of the International Centre for Theoretical Physics, in Trieste, Italy. Rafael has a researcher position at the CINAC-Hospital Puerta del Sur (Hospitales Madrid). This position allows him to combine functional, anatomical and metabolic imaging data to study the effect of incisionless transcranial focused ultrasound on brain networks, and to provide neuroimaging biomarkers for the diagnosis of Parkinson’s disease.
Relevant publications
1. R Martínez-Fernández, R Rodríguez-Rojas, M del Álamo, et al. Focused ultrasound subthalamotomy in patients with asymmetric Parkinson’s disease: a pilot study. The Lancet Neurology 17 (1), 54-63 (2018).
2. R Rodriguez-Rojas, M Carballo-Barreda, L Alvarez, J Guridi, N Pavon, I Garcia-Maeso, R Macías, MC Rodriguez-Oroz, JA Obeso. Subthalamotomy for Parkinson’s disease: clinical outcome and topography of lesions. J Neurol Neurosurg Psychiatry, jnnp-2017-316241. (2017)
3. R Rodríguez-Rojas, C Machado, K Batista, M Carballo, G Leisman. Neuroimages in autism. In: Translational Approaches to Autism Spectrum Disorder, 95-117. Ed. Springer (2015).
4. R Rodriguez-Rojas, C Machado, L Alvarez, M Carballo, M Estevez, J Perez-Nellar, N Pavon, M Chinchilla, FR Carrick, P DeFina. Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS. Brain injury 27 (11), 1320-1329 (2013).
5. L Alvarez, R Macías, N Pavón, G López, MC Rodríguez-Oroz, R Rodriguez-Rojas, et al. Therapeutic efficacy of unilateral subthalamotomy in Parkinson’s disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry 80 (9), 979-985 (2009).